PHILADELPHIA (CBS) - The term is VTE prophylaxis and although it might sound like alphabet soup it has become a very important part of hospital care. The reason why this is important is because ...

Given the dearth of randomized controlled trials available with regard to VTE in patients with multiple myeloma, a simplified, expert-based approach to prophylaxis at various stages of MM, treated ...

Approximately 65% of patients with either low or high risk for venous thromboembolism events received excessive prophylaxis, according to findings published in JAMA Internal Medicine.“National ...

Venous thromboembolism is a significant problem in the care of patients with cancer, increasing morbidity, mortality and costs of care. They are at a much higher risk of developing VTE — up to ...

Perioperative venous thromboembolism (VTE) prophylaxis is beneficial only for surgical patients with Caprini scores of ≥7, according to a meta-analysis published online Jan. 23 in the Annals of ...

The investigators reported a 0.5% incidence of new VTE among 21,000 patients admitted to the hospital with cirrhosis over the study period. Neither the patient characteristics nor the etiology of ...

Guidelines for VTE Prophylaxis in Nonsurgical Patients Issued New evidence-based clinical practice guidelines have been issued for the prophylaxis of venous thromboembolism (VTE) in nonsurgical ...

HOUSTON --The risk of re-bleeding after intracranial hemorrhage did not increase when patients received early prophylaxis for venous thromboembolism (VTE), a retrospective review showed.

Dr. Nigel Key and Dr. Anna Falanga join us for a conversation on the updated ASCO VTE prophylaxis and treatment in patients with cancer guideline. They discuss recent evidence assessing apixaban for ...

The risk of venous thromboembolism (VTE) is known to be increased in patients with IBD. However, no specific consensus statements exist regarding the prevention of postoperative VTE in patients ...

NICE's guideline on venous thromboembolism in over 16s, sections 1.4 to 1.15, should be referred to for population-specific recommendations on different timings and types of pharmacological VTE ...